-
Minova received the "Drug Registration Certificate" for Rosuvastatin Calcium Tablets and Atorvastatin Calcium Tablets
Time of Update: 2021-08-13
issued an announcement stating that its joint venture company, Ningbo Kercom Minova Pharmaceutical Co.
, has recently received rosuvastatin calcium tablets and atorva approved and issued by the State Food and Drug Administration.
-
Datong City Market Supervision Administration Announcement on Food Safety Supervision Sampling Inspection Information in 2021 (Phase 1
Time of Update: 2021-03-20
html" class="zdbq" title="Sampling related food information" target="_blank">sampling inspection of foodmate.
html" class="zdbq" title="Dairy related food information" target="_blank">dairy products, foodmate.
html" class="zdbq" title="Dairy related food information" target="_blank">dairy products, foodmate.
html" class="zdbq" title="Dairy related food information" target="_blank">dairy products, foodmate.
-
6 new drugs approved clinically to develop treatment of seizure asleep disease, cancer, stroke medium
Time of Update: 2020-11-15
1, Takeda: TAK-994 tablets of adaptive disorders: TAK-994 is an oral drug-given selective orrexin-2 subject (OX2R) agitant, this product in China has obtained clinical trials implied permission to develop for seizure sleeping sickness, for the first time approved clinical in China.
-
Heavy! A large number of injections through the consistency evaluation, is sunny, Koren, Qilu
Time of Update: 2020-11-08
48 injections have passed the consistency evaluation, Hengrui, Qilu most according to the drug intelligence consistency evaluation data show that so far, a total of 48 injections through or as if through the consistency evaluation (the end of the text attached to the evaluation details table).
-
Junshi BioTrepley single anti-treatment soft tissue sarcoma was qualified by the FDA orphan drug
Time of Update: 2020-10-13
May 2020, a new adaptation application for Therepri monoantigen injections used to treat local progressions or metastatic urethra cancers that have been systematically treated in the past was accepted by the National Drug Administration.
-
Then Le (Nirapali) first-line adaptive disease was approved! The only PARP inhibitor approved for first-line maintenance therapy in all populations of ovarian cancer
Time of Update: 2020-09-26
Dr. Ying Du, founder, chairman and chief executive officer of Redding Pharmaceuticals, said, "Nirapali is the only one approved in China and around the world, and can be used as a single parp inhibitor for first-line and relapsed ovarian cancer maintenance treatment, regardless of the patient's biomarker status.
-
The results of the third batch of national elections will be implemented in Shanghai, Beijing, Shanxi, Jiangsu, Chongqing
Time of Update: 2020-09-18
Chongqing Today, chongqing Municipal Health Insurance Bureau issued a "pre-notice on promoting the implementation of the third batch of centralized procurement and use of state-organized drugs", which shows that Chongqing city intends to formally implement the third batch of national drug prices in November 2020.
-
The Health Insurance Bureau responded with 700,000 "sky-high medicines
Time of Update: 2020-09-06
September 2018, Nosinas sodium injections as a new drug for the treatment of rare diseases that have been listed overseas and are clinically urgently needed were included in the priority review and approval process by the State Drug Administration.
-
Standing at the mouth of the wind but lost money a pharmacy owner's live delivery of goods for a year
Time of Update: 2020-07-24
Text In 2019 , the total size of the live-streaming e-commerce industry reached 433.8 billion yuan In contrast to the particularity of products and services and the scale of policy supervision, the
-
Guangdong 3 pharmacies sold out of the market, the market reshuffle is intensifying
Time of Update: 2020-07-20
" Pharmaceutical Network Market Analysis " Recently, the Guangdong Provincial Drug Administration issued the Qingyuan City Market Supervision Authority on the cancellation of <> notice According to
-
FDA grants ZW25 fast-track eligibility for combined chemotherapy for her2 high expression of stomach cancer patients
Time of Update: 2020-06-09
recently, THE FDA (HTTP://WWW.CHEMDRUG.COM/ARTICLE/11/) GRANTED ZW25 FAST-TRACK ELIGIBILITY TO ACCELERATE ZW25 COMBINED CHEMOTHERAPY FOR PATIENTS WITH HIGH EXPRESSION OF HER2 GASTRIC CANCER ZW25
-
9 million Magpies! More than 20 billion oral anti-sugar drug market blasted
Time of Update: 2020-06-01
Table 1: Main content of drug registration approval (source: company announcement) Figure 1: Annual sales trend of end chemical drugs oral diabetes in China's public medical institutions (unit: mill
-
Information on 51 manufacturers of anti-epidemic materials approved by the State Food and Drug Administration
Time of Update: 2020-02-17
According to the latest epidemic data statistics released by the national health and Health Commission, at 0-24:00 on February 16, 31 provinces (autonomous regions, municipalities directly under the c
-
Get rid of the fog and talk about the future-2019 China Medicine New Smart Forum was successfully held
Time of Update: 2019-12-29
On December 28, 2019, under the guidance of China Pharmaceutical Materials Association, the "2019 China Pharmaceutical new wisdom forum" and the "new wisdom 2019 pharmaceutical industry annual value p
-
Domestic "Peier" will be launched soon
Time of Update: 2019-11-22
Pharmaceutical Network November 22, a few days ago, Watson Biohuman Resources Director, President's Office Director Sun Qing said in public, its heavy products 13 price pneumonia vaccine will soon be
